BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 9973206)

  • 1. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
    Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS
    Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
    Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS
    Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.
    Huang MT; Lou YR; Ma W; Newmark HL; Reuhl KR; Conney AH
    Cancer Res; 1994 Nov; 54(22):5841-7. PubMed ID: 7954412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
    Reddy BS; Rivenson A; Kulkarni N; Upadhyaya P; el-Bayoumy K
    Cancer Res; 1992 Oct; 52(20):5635-40. PubMed ID: 1394188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
    Tanaka T; Kojima T; Suzui M; Mori H
    Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.
    Reddy BS; Maruyama H; Kelloff G
    Cancer Res; 1987 Oct; 47(20):5340-6. PubMed ID: 3652039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
    Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary excess of inorganic selenium during initiation and postinitiation phases of colon carcinogenesis in F344 rats.
    Reddy BS; Sugie S; Maruyama H; Marra P
    Cancer Res; 1988 Apr; 48(7):1777-80. PubMed ID: 3349457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
    Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
    Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
    Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
    Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of experimental colon cancer by genistein.
    Rao CV; Wang CX; Simi B; Lubet R; Kelloff G; Steele V; Reddy BS
    Cancer Res; 1997 Sep; 57(17):3717-22. PubMed ID: 9288778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis.
    Kwon Y; Magnuson BA
    Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.